In the first efficient frontier there is only one gene: the NAB1 gene that codes for EGR1-binding protein 1, which has been reported as a potential tumor suppressor in different cancer types including prostate cancer 22, breast cancer 23, esophageal cancer 24, hepatoma 25, and leukemia 26. Here, NAB1 is linked to neoplasm.